Balancing chocolate’s real cardiovscular benefits with potential risks. Here’s how to choose safer options this Valentine’s Day.
A genetics‑guided drug, compound 6, targets CARD9 to subtly calm gut inflammation in Crohn’s disease, pointing to safer, longer‑lasting, precision treatments.
Kasey Keller, the USMNT goalkeeper through four FIFA World Cups, discusses his non-Hodgkins lymphoma diagnosis in 2010 and what the soccer legend has gone through since.
CVS Health reported $2.9 billion in fourth quarter net income as the company begins to get a handle on costs that have hit its Aetna health insurance business.
Garner Health uses data to identify the country’s best doctors based on quality and cost, then gives its customers’ employees financial incentives to go to them — which can save 12% on healthcare costs.
Health insurer`Oscar Health reported a $352 million fourth quarter loss as the health insurer and its industry battle with an ongoing period of rising healthcare costs.
A public health expert breaks down what TrumpRx is and who, if anyone, is likely to benefit from the latest medical initiative introduced by the White House.
Is the Galleri multi-cancer blood test worth it? A doctor’s analyses of real-world performance data. Learn why no major medical society recommends the test for screening.
Lindsey Vonn is scheduled to ski in the women’s downhill finals at the 2026 Winter Olympics despite completely rupturing her anterior cruciate ligament a week earlier.
If compounded and generic GLP-1 drugs work as well as brand-name versions, they could fill a significant void by offering personalized dosing and greater affordability.